Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

2,498 results
Display

Particulate-Matter Related Respiratory Diseases

Kyung SY, Jeong SH

Particulate matter (PM) is suspended dust that has a diameter of
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Luteolin attenuates migration and invasion of lung cancer cells via suppressing focal adhesion kinase and non-receptor tyrosine kinase signaling pathway

Masraksa W, Tanasawet , Hutamekalin P, Wongtawatchai T, Sukketsiri W

BACKGROUND/OBJECTIVES: Non-small cell lung cancer is mostly recognized among other types of lung cancer with a poor prognosis by cause of chemotherapeutic resistance and increased metastasis. Luteolin has been found...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Psoriasiform Dermatitis Related with T-Cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains Inhibitor in a Patient with Non-Small-Cell Lung Cancer

Choi Y, Jang D, Byun HJ, Oh SJ, Kim CR, Park JH, Lee JH, Lee DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation

Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Yoon YI, Cho HD, Kwon JH, Chung YK, Kang SH, Choi JU, Jung IJ, Lee SG

BACKGROUND: Hepatocellular carcinoma (HCC) recurrence and development of de novo malignancy (DNM) after liver transplantation (LT) are the major causes of late recipient death. METHODS: We analyzed the incidence of extrahepatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1

Cui F, Zhou Q, Xiao K, Ma S

PURPOSE: The goal of this study was to explore the effects of hsa-let-7g on cell proliferation and apoptosis, and elucidate its role in lung cancer development. MATERIALS AND METHODS: The expression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions

Lee G, Park H, Bak SH, Lee HY

Ideally, radiomics features and radiomics signatures can be used as imaging biomarkers for diagnosis, staging, prognosis, and prediction of tumor response. Thus, the number of published radiomics studies is increasing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Third Asian Radiology Forum: Screening Programs in Asia

Chien N, Chen JY, Chen SJ, Chang YC

According to reports presented at the Asian Radiology Forum 2017 in Taipei, the landscape of screening in Asia is growing, and the role of radiologists is also evolving. The Asian...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Applying Extended Theory of Planned Behavior for Lung Cancer Patients Undergone Pulmonary Resection: Effects on Self-Efficacy for Exercise, Physical Activities, Physical Function, and Quality of Life

Lim Y, Lee H, Kim DH, Kim YD

PURPOSE: This study aims to examine the effects of nursing interventions based on the Extended Theory of Planned Behavior (ETPB) regarding self-efficacy for exercise (SEE), physical activity (PA), physical function...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

Lim SM, Hong MH, Kim HR

Immune checkpoint inhibitors (ICIs) have shown remarkable benefit in the treatment of patients with non-small-cell lung cancer (NSCLC) and have emerged as an effective treatment option even in the first-line...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the risks of combustible cigarettes, e-cigarettes, and heated tobacco products

Cho HJ

E-cigarettes (ECs) and heated tobacco products (HTPs) have become popular in Korea; hence, it is important to determine whether ECs and HTPs are less hazardous than combustible cigarettes (CCs). In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Performances of CYFRA 21-1, Carcinoembryonic Antigen and Their Combination for Lung Cancer Diagnosis

Kim JJ, Ahn HJ, Park Y

BACKGROUND: The aim of this study was to compare the efficiency of cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) for the diagnosis of lung cancer and to establish...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma

Kang BJ, Ra SW, Lee K, Lim S, Son SH, Ahn JJ, Kim BC

BACKGROUND: Circulating tumor cells (CTCs) are frequently detected in patients with advanced-stage malignant tumors and could act as a predictor of poor prognosis. However, there is a paucity of data...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status of Immunotherapy for Lung Cancer and Future Perspectives

Kim HC, Choi CM

Lung cancer remains the most common cause of cancer-related deaths worldwide. Although there are many possible treatments, including targeted therapies such as epidermal growth factor receptor tyrosine kinase inhibitors and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer

Kim DY, Song C, Kim SH, Kim YJ, Lee JS, Kim JS

PURPOSE: It is unclear whether adding concurrent chemotherapy (CT) to definitive radiotherapy (RT) following induction CT is a tolerable and cost effective treatment for non-small-cell lung cancer (NSCLC) patients aged...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Local ablative radiotherapy for oligometastatic non-small cell lung cancer

Suh YG, Cho J

In metastatic non-small cell lung cancer (NSCLC), the role of radiotherapy (RT) has been limited to palliation to alleviate the symptoms. However, with the development of advanced RT techniques, recent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of Artificial Intelligence in Lung Cancer Screening

Lee SM, Park CM

Lung cancer is a leading cause of deaths due to cancer, worldwide. At present, low-dose computed tomography (CT) is the only established screening method for reducing lung cancer mortality. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Prediction Model for Lung Cancer Screening

Kim TJ, Kim HY, Goo JM, Sun JS

Lung cancer screening in high-risk subjects using low-dose CT can reduce mortality by 20%. Current evidence suggests that the development of a risk prediction model for lung cancer is one...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lung Cancer Screening with Low-Dose CT: Current Status in Other Countries

Goo JM

Lung cancer is the leading cause of death from cancer worldwide. The most effective way to reduce lung cancer mortality is early detection and treatment. Two large randomized controlled trials...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Significant Abnormalities Other than Lung Cancer in Korean Lung Cancer CT Screening

Yoon SH, Hong J, Hwang EJ, Kim H, Lim HJ, Suh YJ, Kim HY, Goo JM

A low-dose chest CT is performed for early detection of lung cancer, but the CT scan frequently shows several incidental abnormalities. Identification of the incidental findings may enable early detection...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
National Lung Cancer Screening in Korea: Introduction and Imaging Quality Control

Kim HY

Before the implementation of lung cancer screening as a national cancer screening program, the Korean Lung Cancer Screening Project was performed to evaluate its effectiveness and feasibility. A national lung...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr